[Form 4] Aspira Women's Health Inc. Insider Trading Activity

Rhea-AI Filing Summary

Aspira Women's Health Inc. insider purchase and holdings update. Director Jack W. Schuler, as sole trustee of the Jack W. Schuler Living Trust, reported purchases and existing holdings in AWHL securities. On 09/17/2025 he purchased 1,111,111 shares of common stock at $0.45 per share and now beneficially owns 3,823,829 shares indirectly through the Living Trust. The filing also reports warrants totaling 2,661,422 underlying common shares across multiple strike prices and expirations, including an acquisition of 833,333 warrants exercisable at $0.75 (expiring 09/17/2030). A small disposition of 6,536 common shares and a prior disposal of 6,536 warrants at $2.25 are noted. The report is signed by Jack W. Schuler on 09/18/2025.

Insights

Securities Analyst

TL;DR: Significant insider purchase increases trust's indirect stake, a material ownership change to note.

The 1,111,111-share purchase at $0.45 is a sizable open-market acquisition by a company director acting as trustee, raising indirect beneficial ownership to 3,823,829 shares. Combined with outstanding warrants representing over 2.6 million underlying shares, the director's economic exposure to AWHL is concentrated and meaningful. This transaction may affect perceived insider conviction and potential future dilution if warrants are exercised, but the form contains no forward-looking statements or company commentary.

Corporate Governance Expert

TL;DR: Routine Section 16 reporting of trustee-held securities; disclosure is timely and clarifies indirect ownership.

The filing explains the indirect ownership through the Jack W. Schuler Living Trust and lists both acquisitions and small dispositions across common stock and warrants. From a governance perspective, the form fulfills disclosure obligations by identifying relationship to issuer and precise security instruments, strike prices, exercisability dates, and post-transaction holdings. No amendments or plan-based (10b5-1) designation are indicated.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHULER JACK W

(Last) (First) (Middle)

C/O ASPIRA WOMEN'S HEALTH INC

12117 BEE CAVES RD, BLDG 3-100

(Street)

AUSTIN, 78738

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		P		1,111,111	A	$0.45	3,823,829	I	By Jack W. Schuler Living Trust(1)
Common Stock								6,536	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (Right to Buy)	$0.75	09/17/2025		P		833,333		09/17/2025	09/17/2030	Common Stock, par value $0.001	833,333	$0	833,333	I	By Jack W. Schuler Living Trust(1)
Warrant (Right to Buy)	$2.25							07/09/2024	07/09/2027	Common Stock	6,536		6,536	D
Warrant (Right to Buy)	$0.25							03/12/2025	03/12/2030	Common Stock	1,801,265		1,801,265	I	By Jack W. Schuler Living Trust(1)
Warrant (Right to Buy)	$4.13							07/26/2024	07/26/2029	Common Stock	28,500		28,500	I	By Jack W. Schuler Living Trust(1)
Warrant (Right to Buy)	$4.13							08/25/2022	01/26/2029	Common Stock	8,888		8,888	I	By Jack W. Schuler Living Trust(1)

Explanation of Responses:

1. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust") and in such capacity may be deemed to beneficially own the securities held by the Living Trust.

	/s/ Jack W Schuler	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AWHL director Jack W. Schuler report on Form 4?

He reported acquiring 1,111,111 common shares on 09/17/2025 at $0.45 per share and holding 3,823,829 shares indirectly via his Living Trust.

How many warrants does the filing disclose and what are key strike prices?

The filing discloses warrants underlying 2,661,422 common shares across strikes including $0.75, $0.25, $4.13, and $2.25 with varied expirations to 2030.

Did the report show any dispositions by the reporting person?

Yes, the form reports a disposition of 6,536 common shares and a disposition of 6,536 warrants at a $2.25 strike.

How is ownership held according to the Form 4?

Ownership is reported indirectly through the Jack W. Schuler Living Trust, for which Jack W. Schuler is sole trustee.

When was the Form 4 signed?

The Form 4 is signed by Jack W. Schuler on 09/18/2025.